RNF43 and familial pancreatic carcinoma: RNF43 mutations are the most common Wnt pathway mutations in pancreatic cancer, observed in 5-10% of cases (Fig. 2) (Bailey et al., 2016; Tu et al., 2019; Witkiewicz et al., 2015).